UK Outlines Issues With Illumina's $1B DNA Sequencing Buy
DNA-sequencing company Illumina Inc.'s proposed $1.2 billion takeover of Pacific Biosciences of California Inc. has run into resistance from the U.K.'s antitrust watchdog amid concerns that the merger would threaten the...To view the full article, register now.
Already a subscriber? Click here to view full article